My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$VRX {{ '2016-08-11T13:07:55+0000' | timeago}} • Announcement

Canadian drug maker $VRX confirmed that the company is facing a federal investigation and it has been "fully cooperating" with the authorities in the matter. The company said it had disclosed in October 2015 about the investigation being conducted by the U.S. Attorney's Office for the Southern District of New York involving $VRX.

User Jasmin Crosswhite {{ '2017-01-24T20:22:04+0000' | timeago}}

$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?

User ritesh salot {{ '2017-01-24T14:22:47+0000' | timeago}}

Baba

User Robert Smith {{ '2017-01-24T13:01:54+0000' | timeago}}

$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

$COF {{ '2017-01-24T21:43:32+0000' | timeago}} • Announcement

$COF's net revenue increased 2% to $6.6Bil in 4Q16 compared to $6.2Bil in the prior year quarter. Period-end total deposits increased $10.8Bil or 5% to $236.8Bil and average deposits increased $10Bil or 4% to $232.2Bil.

$SYK {{ '2017-01-24T21:36:17+0000' | timeago}} • Announcement

$SYK expects 2017 organic sales growth to be 5.5-6.5%. Adjusted diluted EPS is expected to be $1.40-1.45 in 1Q17 and $6.35-6.45 in the full year 2017.

$COF {{ '2017-01-24T21:34:28+0000' | timeago}} • Announcement

$COF reported a lower profit in 4Q16, hurt by higher provision for credit losses. Net income dropped 14% to $791MM or $1.45 per share. The company recorded a charge of $72MM consisting of a build in the the U.K. Payment Protection Insurance customer refund reserve and an impairment associated with certain acquired intangible and software assets.

$SYK {{ '2017-01-24T21:30:30+0000' | timeago}} • Announcement

Medical technology company $SYK reported a decrease in 4Q16 earnings. Net earnings decreased 2.3% to $510MM and diluted EPS decreased 2.9% to $1.34 compared to 4Q15. Consolidated net sales of $3.2Bil increased 16.2% in 4Q16 versus last year.

$ISRG {{ '2017-01-24T21:28:33+0000' | timeago}} • Announcement

For 3Q16, $ISRG's Instruments and Accessories revenue rose 18.64% YoverY to $386.3MM, helped by growth in U.S. general surgery procedures and worldwide urologic procedures. Service revenue grew by 12.06% to $134.7MM, while Systems revenue for the quarter rose by 2.25% to $235.9MM from a year ago.